CN109641019A - 用于治疗或预防草酸盐相关病症的组合物和方法 - Google Patents

用于治疗或预防草酸盐相关病症的组合物和方法 Download PDF

Info

Publication number
CN109641019A
CN109641019A CN201780036943.1A CN201780036943A CN109641019A CN 109641019 A CN109641019 A CN 109641019A CN 201780036943 A CN201780036943 A CN 201780036943A CN 109641019 A CN109641019 A CN 109641019A
Authority
CN
China
Prior art keywords
pharmaceutical composition
capsule
oxalates
disease
oxalate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780036943.1A
Other languages
English (en)
Chinese (zh)
Inventor
E.林德内
M.阿克曼
A.斯约格林
O.麦克里昂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxthera Intellectual Property AB
Original Assignee
Oxthera Intellectual Property AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Intellectual Property AB filed Critical Oxthera Intellectual Property AB
Publication of CN109641019A publication Critical patent/CN109641019A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201780036943.1A 2016-06-13 2017-06-13 用于治疗或预防草酸盐相关病症的组合物和方法 Pending CN109641019A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1650828-5 2016-06-13
SE1650828 2016-06-13
PCT/EP2017/064422 WO2017216165A1 (en) 2016-06-13 2017-06-13 Compositions and methods for the treatment or prevention of oxalate-related disorders

Publications (1)

Publication Number Publication Date
CN109641019A true CN109641019A (zh) 2019-04-16

Family

ID=59067657

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780036943.1A Pending CN109641019A (zh) 2016-06-13 2017-06-13 用于治疗或预防草酸盐相关病症的组合物和方法

Country Status (12)

Country Link
US (2) US10765709B2 (https=)
EP (1) EP3468572B1 (https=)
JP (1) JP7016353B2 (https=)
CN (1) CN109641019A (https=)
AU (1) AU2017286220A1 (https=)
CA (1) CA3023042A1 (https=)
ES (1) ES2913398T3 (https=)
IL (1) IL263477A (https=)
JO (1) JOP20180110A1 (https=)
MA (1) MA45226A (https=)
TN (1) TN2018000420A1 (https=)
WO (1) WO2017216165A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607262A (zh) * 2019-09-25 2019-12-24 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
CN115335066A (zh) * 2020-01-14 2022-11-11 同生运营公司 经工程化以治疗其中草酸盐有害的病症的细菌

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders
US20210386793A1 (en) * 2018-10-04 2021-12-16 Oxthera Intellectual Property Ab New medical use of oxalate-reducing bacteria
EP3839039A1 (en) * 2019-12-16 2021-06-23 4D Pharma Research Limited Providing bacterial biomass with improved storage stability
CA3175041A1 (en) * 2020-03-10 2021-09-16 Federation Bio Inc. Microbial consortia for the treatment of disease
EP4043018A1 (en) * 2021-02-10 2022-08-17 Charité - Universitätsmedizin Berlin Composition and method for reducing oxalate levels in patients receiving maintenance dialysis
CA3216136A1 (en) * 2021-04-30 2022-11-03 Aaron Blake Cowley Compositions for preserving anaerobic microorganisms and methods of making and using the same
WO2023102091A2 (en) * 2021-12-01 2023-06-08 Federation Bio, Inc. Microbial consortia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242230B1 (en) * 1992-05-11 2001-06-05 University Of Florida Process for microencapsulating cells
EP1771201A2 (en) * 2004-06-15 2007-04-11 OxThera, Inc., Compositions and methods for treating or preventing oxalate-related disease
WO2007070677A2 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG61712B1 (bg) * 1994-12-29 1998-04-30 "Ел Би Булгарикум" ЕАД закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
JP4996780B2 (ja) 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
WO2005097176A2 (en) 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Modulating oxalate transport
CA2608862C (en) 2004-06-11 2020-05-05 Trustees Of Tufts College Silk-based drug delivery system
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
JP5193626B2 (ja) 2008-02-20 2013-05-08 日本曹達株式会社 微生物農薬製剤の保存方法
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242230B1 (en) * 1992-05-11 2001-06-05 University Of Florida Process for microencapsulating cells
EP1771201A2 (en) * 2004-06-15 2007-04-11 OxThera, Inc., Compositions and methods for treating or preventing oxalate-related disease
WO2007070677A2 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SIDHU ET AL: "RAPID REVERSAL OF HYPEROXALURIA IN A RAT MODEL AFTER PROBIOTIC ADMINISTRATION OF OXALOBACTER FORMIGENES", 《JOURNAL OF UROL》 *
SUBRAMANIAN VAIDYANATHAN ET AL.: "Hyperoxaluria, Hypocitraturia, Hypomagnesuria, and Lack of Intestinal Colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis", 《THE SCIENTIFIC WORLD JOURNAL》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607262A (zh) * 2019-09-25 2019-12-24 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
CN110607262B (zh) * 2019-09-25 2022-03-25 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
CN115335066A (zh) * 2020-01-14 2022-11-11 同生运营公司 经工程化以治疗其中草酸盐有害的病症的细菌

Also Published As

Publication number Publication date
US20190125807A1 (en) 2019-05-02
AU2017286220A1 (en) 2018-12-06
TN2018000420A1 (en) 2020-06-15
EP3468572A1 (en) 2019-04-17
WO2017216165A1 (en) 2017-12-21
JOP20180110A1 (ar) 2019-01-30
ES2913398T3 (es) 2022-06-02
CA3023042A1 (en) 2017-12-21
US10765709B2 (en) 2020-09-08
US20210052670A1 (en) 2021-02-25
EP3468572B1 (en) 2022-03-02
IL263477A (en) 2019-01-31
JP2019521182A (ja) 2019-07-25
MA45226A (fr) 2019-04-17
JP7016353B2 (ja) 2022-02-04

Similar Documents

Publication Publication Date Title
CN109641019A (zh) 用于治疗或预防草酸盐相关病症的组合物和方法
Domínguez‐Muñoz Pancreatic exocrine insufficiency: diagnosis and treatment
Koff et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation
DiBaise et al. Intestinal rehabilitation and the short bowel syndrome: part 2
JP6755920B2 (ja) 胆汁酸捕捉剤の胃内滞留型徐放性経口剤形
CN107405309B (zh) 用于治疗肥胖症和相关代谢紊乱的奥利司他和阿卡波糖的调释组合物
JP2014133775A (ja) 新規な置換ベンズイミダゾール投与形態およびそれらの使用方法
Shah et al. Hyperoxaluria
Alizadeh et al. A comparison between dextranomer/hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux
TWI469785B (zh) 用於治療代謝性疾病之膳食纖維組成物
Hurtado et al. Successful treatment for a gastric persimmon bezoar in a pony using nasogastric lavage with a carbonated cola soft drink
CN102137670A (zh) 结肠净化方法和试剂盒
Fürst et al. Enteric‐coated cholylsarcosine microgranules for the treatment of short bowel syndrome
US20210386793A1 (en) New medical use of oxalate-reducing bacteria
Tomson et al. Nephrolithiasis and Nephrocalcinosis
Babinets Liliya EVALUATION OF MORPHOLOGICAL GASTRODUODENAL CHANGES OUT-PATIENTS WITH CHRONIC PANCREATITIS AND CHRONIC H. PYLORI-GASTRITIS COMORBIDITY UNDER THE INFLUENCE OF AN OPTIMIZED COMPLEX TREATMENT PROGRAM
US20130078287A1 (en) Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist
CN107802827B (zh) 一种重组激肽释放酶冻干粉制剂
Abboud Nephrolithiasis in Patients with Gastrointestinal Disorders
WO2023209258A1 (es) Composición para la rehabilitación intestinal
Banks Long-term management of patients with chronic pancreatitis
CA3260258A1 (en) PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING LANTHAN AND ITS USE IN A METHOD OF TREATMENT OF HYPEROXALURIA
CN114903985A (zh) 一种组合物及其在防治高草酸尿症方面的应用
Kiran et al. Chapter-6 Medicinal Herbs for Urolithiasis
Mallenahalli et al. 48: Urolithiasis—Ureteral Surgical Management

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190416

WD01 Invention patent application deemed withdrawn after publication